Waters Co. (WAT) Receives Average Recommendation of “Hold” from Brokerages

Shares of Waters Co. (NYSE:WAT) have been given an average rating of “Hold” by the nineteen analysts that are currently covering the company, MarketBeat Ratings reports. Three investment analysts have rated the stock with a sell rating, eleven have given a hold rating and four have assigned a buy rating to the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $201.25.

A number of research firms recently weighed in on WAT. Zacks Investment Research raised Waters from a “sell” rating to a “hold” rating in a research note on Friday, August 17th. UBS Group dropped their price target on Waters from $210.00 to $200.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 24th. Cleveland Research raised Waters from a “sell” rating to a “neutral” rating in a research note on Thursday, October 11th. ValuEngine raised Waters from a “hold” rating to a “buy” rating in a research note on Tuesday, November 27th. Finally, JPMorgan Chase & Co. lowered their price objective on Waters from $200.00 to $185.00 and set a “neutral” rating for the company in a research note on Wednesday, October 24th.

In other news, Director Thomas P. Salice sold 3,500 shares of the firm’s stock in a transaction on Wednesday, October 31st. The stock was sold at an average price of $192.00, for a total value of $672,000.00. Following the completion of the transaction, the director now directly owns 20,911 shares of the company’s stock, valued at $4,014,912. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Christopher A. Kuebler sold 8,000 shares of the firm’s stock in a transaction on Friday, November 16th. The stock was sold at an average price of $199.67, for a total value of $1,597,360.00. Following the completion of the transaction, the director now directly owns 18,911 shares of the company’s stock, valued at $3,775,959.37. The disclosure for this sale can be found here. Corporate insiders own 0.98% of the company’s stock.

Institutional investors have recently bought and sold shares of the company. Alps Advisors Inc. purchased a new stake in shares of Waters in the second quarter worth $478,000. Raymond James Financial Services Advisors Inc. raised its position in shares of Waters by 5.8% in the second quarter. Raymond James Financial Services Advisors Inc. now owns 7,118 shares of the medical instruments supplier’s stock worth $1,378,000 after buying an additional 391 shares in the last quarter. TD Asset Management Inc. raised its position in shares of Waters by 74.0% in the second quarter. TD Asset Management Inc. now owns 43,526 shares of the medical instruments supplier’s stock worth $8,427,000 after buying an additional 18,509 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. raised its position in shares of Waters by 5.4% in the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 244,477 shares of the medical instruments supplier’s stock worth $47,328,000 after buying an additional 12,497 shares in the last quarter. Finally, Smith Asset Management Group LP raised its position in shares of Waters by 18.2% in the second quarter. Smith Asset Management Group LP now owns 164,388 shares of the medical instruments supplier’s stock worth $31,864,000 after buying an additional 25,303 shares in the last quarter. 98.51% of the stock is owned by hedge funds and other institutional investors.

WAT stock traded down $4.94 during midday trading on Monday, reaching $188.94. 576,774 shares of the stock were exchanged, compared to its average volume of 517,882. The firm has a market capitalization of $14.69 billion, a P/E ratio of 25.23, a P/E/G ratio of 2.32 and a beta of 0.97. Waters has a 52 week low of $167.93 and a 52 week high of $220.20. The company has a quick ratio of 5.93, a current ratio of 6.63 and a debt-to-equity ratio of 0.61.

Waters (NYSE:WAT) last issued its quarterly earnings data on Tuesday, October 23rd. The medical instruments supplier reported $1.92 earnings per share for the quarter, topping analysts’ consensus estimates of $1.90 by $0.02. The business had revenue of $578.02 million for the quarter, compared to analyst estimates of $587.43 million. Waters had a return on equity of 30.68% and a net margin of 2.32%. Waters’s quarterly revenue was up 2.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.77 EPS. As a group, equities research analysts expect that Waters will post 8.05 EPS for the current fiscal year.

About Waters

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in the United States, Europe, Asia, and internationally. It designs, manufactures, sells, and services high and ultra performance liquid chromatography technology, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Further Reading: What is the Federal Reserve?

Analyst Recommendations for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit